Scinai Immunotherapeutics Ltd.
SCNI
$0.51
-$0.03-5.07%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.43% | -67.85% | -59.67% | -- | -29.33% |
| Total Receivables | -22.58% | 16.81% | -40.71% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.06% | -27.16% | 11.27% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.50% | 2.90% | -6.43% | -- | -- |
| Total Current Assets | -14.09% | -58.82% | -56.10% | -- | -28.62% |
|
|
|||||
| Total Current Assets | -14.09% | -58.82% | -56.10% | -- | -28.62% |
| Net Property, Plant & Equipment | -13.43% | -7.68% | -8.05% | -- | -13.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -13.55% | -20.27% | -23.03% | -- | -22.00% |
|
|
|||||
| Total Accounts Payable | 8.24% | 0.15% | -29.72% | -- | 2.40% |
| Total Accrued Expenses | -2.82% | -- | -8.01% | -- | -24.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -22.41% | 36.54% | 7.07% | -- | 67.53% |
| Total Finance Division Other Current Liabilities | -60.00% | 48.31% | -- | -- | -- |
| Total Other Current Liabilities | -60.00% | 48.31% | -- | -- | -- |
| Total Current Liabilities | -12.24% | 26.79% | 1.46% | -- | -2.95% |
|
|
|||||
| Total Current Liabilities | -12.24% | 26.79% | 1.46% | -- | -2.95% |
| Long-Term Debt | 13.08% | -98.52% | -98.66% | -- | 7.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.26% | 144.69% | 75.91% | -- | -42.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 0.00% | -96.88% | -- | 8,869.70% |
| Total Liabilities | 1.50% | -82.01% | -84.25% | -- | 13.27% |
|
|
|||||
| Common Stock & APIC | 5.20% | 3.61% | 3.45% | -- | -4.58% |
| Retained Earnings | -7.07% | 4.06% | 3.92% | -- | -2.04% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Common Equity | -43.08% | 130.63% | 195.21% | -- | -195.17% |
|
|
|||||
| Preferred Stock Redeemable | 0.00% | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -43.08% | 130.63% | 195.21% | -- | -195.17% |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.78% | 207.88% | 318.36% | -- | -195.17% |
|
|
|||||